Updated efficacy, safety, and biomarker analysis in patients with TRK fusion lung cancer treated with larotrectinib Meeting Abstract


Authors: Lin, J. J.; Tan, D. S. W.; Kummar, S.; Moreno, V.; Leyvraz, S.; Dubashi, B.; Parambath, H.; Burcoveanu, D. I.; Neu, N.; Leserer, S.; Seidel, H.; Mussi, C. E.; Shen, L.; Drilon, A.
Abstract Title: Updated efficacy, safety, and biomarker analysis in patients with TRK fusion lung cancer treated with larotrectinib
Meeting Title: 2024 World Conference on Lung Cancer
Keywords: lung cancer; larotrectinib; ntrk gene fusion
Journal Title: Journal of Thoracic Oncology
Volume: 19
Issue: 10 Suppl.
Meeting Dates: 2024 Sep 7-10
Meeting Location: San Diego, CA
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2024-10-01
Start Page: S77
Language: English
ACCESSION: WOS:001337925600128
PROVIDER: wos
DOI: 10.1016/j.jtho.2024.09.138
Notes: Meeting Abstract: MA06.12 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon